Alvotech and Advanz Pharma Receive Marketing Authorizations for Gobivaz, a Biosimilar to Simponi (golimumab), from the MHRA.

Alvotech and Advanz Pharma have announced the receipt of marketing authorisations from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for all four formulations of Gobivaz - Alvotech ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

While investment has slowed in radiopharmaceuticals, analysts predict increased interest to come as Novartis shows just how successful radiopharmaceuticals can be.

This report, published by Towards Healthcare, a sister firm of Precedence Research, provides a comprehensive analysis of the ...

Q3 2025 Earnings Call November 6, 2025 8:00 AM ESTCompany ParticipantsAndrew Barnett - Head of Investor RelationsPascal Soriot - ...

The 5 th annual Pre-Filled Syringes West Coast conference will reconvene on the 15 th – 16 th June in San Diego, CA. As the event draws closer the agenda will offer a variety of key topics surrounding ...

The MarketWatch News Department was not involved in the creation of this content.-- VYVGART(R) SC is first and only neonatal Fc receptor blocker approved to treat CIDP -- Authoriz ...

Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia. The recommendation by the EMA's human ...

Reports Net Revenues of $191.8 million for the Three Months Ended September 30, 2025GAAP net income of $17.4 million, or $0.37 per share, for the third quarterAdjusted non-GAAP net income of $44.7 ...

Sustainability Initiatives: There is a clear market shift toward biodegradable and recyclable rubber stoppers. Leading manufacturers are innovating with natural rubber blends and sustainable synthetic ...